| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantigens | 13 | 2014 | 890 | 1.900 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 5 | 2018 | 97 | 1.310 |
Why?
|
| Nitric Oxide | 19 | 2021 | 2149 | 1.240 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 2014 | 393 | 1.050 |
Why?
|
| RNA, Messenger | 20 | 2023 | 12801 | 1.010 |
Why?
|
| Liver Cirrhosis, Biliary | 7 | 2014 | 108 | 1.000 |
Why?
|
| Activin Receptors, Type I | 5 | 2020 | 134 | 0.930 |
Why?
|
| Iron Overload | 3 | 2022 | 245 | 0.870 |
Why?
|
| Nuclear Proteins | 18 | 2020 | 5804 | 0.850 |
Why?
|
| Antigens, Nuclear | 6 | 2009 | 183 | 0.820 |
Why?
|
| Atrial Natriuretic Factor | 4 | 2018 | 350 | 0.810 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2020 | 846 | 0.790 |
Why?
|
| Carbon Monoxide Poisoning | 5 | 2021 | 65 | 0.790 |
Why?
|
| Autoantibodies | 11 | 2024 | 2121 | 0.790 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2022 | 85 | 0.770 |
Why?
|
| Vasoconstriction | 6 | 2019 | 592 | 0.740 |
Why?
|
| Antibodies, Antinuclear | 7 | 2020 | 342 | 0.740 |
Why?
|
| Cytoplasmic Structures | 2 | 2014 | 21 | 0.720 |
Why?
|
| Respiratory Therapy | 2 | 2018 | 125 | 0.680 |
Why?
|
| Cyclic GMP | 6 | 2019 | 394 | 0.680 |
Why?
|
| Cation Transport Proteins | 2 | 2022 | 326 | 0.670 |
Why?
|
| Nuclear Physics | 6 | 2014 | 73 | 0.660 |
Why?
|
| Calciphylaxis | 2 | 2017 | 129 | 0.630 |
Why?
|
| Autoimmune Diseases | 11 | 2014 | 2257 | 0.610 |
Why?
|
| Hepatic Veno-Occlusive Disease | 4 | 2017 | 220 | 0.610 |
Why?
|
| Calcium Hydroxide | 1 | 2018 | 16 | 0.610 |
Why?
|
| Calcium-Binding Proteins | 4 | 2021 | 1083 | 0.600 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2021 | 835 | 0.600 |
Why?
|
| Cytoplasmic Granules | 5 | 2011 | 574 | 0.590 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2018 | 344 | 0.580 |
Why?
|
| Myocytes, Cardiac | 6 | 2018 | 1682 | 0.580 |
Why?
|
| Mammals | 1 | 2023 | 1135 | 0.570 |
Why?
|
| Hydrogen Sulfide | 3 | 2024 | 147 | 0.560 |
Why?
|
| Hypertension, Pulmonary | 6 | 2020 | 1605 | 0.560 |
Why?
|
| Guanylate Cyclase | 6 | 2019 | 206 | 0.540 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2017 | 549 | 0.530 |
Why?
|
| Leigh Disease | 3 | 2024 | 89 | 0.530 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2016 | 163 | 0.530 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2014 | 463 | 0.470 |
Why?
|
| MicroRNAs | 6 | 2018 | 3803 | 0.450 |
Why?
|
| Pyrazoles | 5 | 2020 | 2028 | 0.450 |
Why?
|
| Elementary Particles | 4 | 2014 | 50 | 0.440 |
Why?
|
| Ribonucleoproteins | 4 | 2013 | 359 | 0.440 |
Why?
|
| Atherosclerosis | 5 | 2020 | 3433 | 0.430 |
Why?
|
| Microbodies | 1 | 2013 | 34 | 0.430 |
Why?
|
| Phototherapy | 5 | 2021 | 368 | 0.420 |
Why?
|
| Cardiomegaly | 1 | 2016 | 591 | 0.420 |
Why?
|
| Quinone Reductases | 2 | 2024 | 24 | 0.420 |
Why?
|
| Animals | 84 | 2024 | 169285 | 0.420 |
Why?
|
| Angiotensin II | 1 | 2016 | 844 | 0.420 |
Why?
|
| Proteins | 8 | 2014 | 6009 | 0.400 |
Why?
|
| Growth Differentiation Factor 10 | 2 | 2023 | 4 | 0.400 |
Why?
|
| Pyrimidines | 5 | 2020 | 3048 | 0.390 |
Why?
|
| Iron | 5 | 2022 | 1813 | 0.380 |
Why?
|
| Hemoglobins | 6 | 2021 | 1531 | 0.370 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2023 | 484 | 0.370 |
Why?
|
| Administration, Inhalation | 8 | 2021 | 1169 | 0.330 |
Why?
|
| RNA-Binding Proteins | 4 | 2014 | 1891 | 0.330 |
Why?
|
| Neoplasm Proteins | 6 | 2004 | 3604 | 0.320 |
Why?
|
| Bone Morphogenetic Protein 6 | 2 | 2020 | 58 | 0.320 |
Why?
|
| Endoribonucleases | 4 | 2014 | 231 | 0.320 |
Why?
|
| Antigens | 2 | 2014 | 1443 | 0.310 |
Why?
|
| Electron Transport Complex I | 2 | 2021 | 152 | 0.310 |
Why?
|
| Minor Histocompatibility Antigens | 6 | 2017 | 303 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 1327 | 0.310 |
Why?
|
| Anemia | 2 | 2015 | 1514 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 21 | 2023 | 22380 | 0.300 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2019 | 1494 | 0.300 |
Why?
|
| RNA Interference | 7 | 2021 | 2832 | 0.290 |
Why?
|
| Mice | 45 | 2024 | 82049 | 0.290 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2015 | 2474 | 0.290 |
Why?
|
| Signal Transduction | 15 | 2020 | 23648 | 0.290 |
Why?
|
| Models, Theoretical | 6 | 2014 | 3573 | 0.280 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2000 | 394 | 0.280 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7876 | 0.280 |
Why?
|
| Hemopexin | 2 | 2017 | 33 | 0.280 |
Why?
|
| B-Lymphocytes | 5 | 2012 | 4793 | 0.280 |
Why?
|
| Immunoglobulin G | 6 | 2014 | 4568 | 0.270 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1184 | 0.260 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2005 | 435 | 0.260 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2006 | 52 | 0.260 |
Why?
|
| Vascular Resistance | 3 | 2019 | 939 | 0.260 |
Why?
|
| Transfection | 8 | 2018 | 5756 | 0.260 |
Why?
|
| RNA Caps | 1 | 2005 | 73 | 0.250 |
Why?
|
| Skin | 2 | 2017 | 4505 | 0.250 |
Why?
|
| Haptoglobins | 2 | 2017 | 165 | 0.250 |
Why?
|
| Carbon Monoxide | 4 | 2021 | 560 | 0.250 |
Why?
|
| Cell Nucleus | 3 | 2005 | 2885 | 0.250 |
Why?
|
| Immunoblotting | 9 | 2015 | 1648 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2496 | 0.240 |
Why?
|
| Cells, Cultured | 15 | 2021 | 19025 | 0.240 |
Why?
|
| Mitochondria | 6 | 2024 | 3683 | 0.240 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2005 | 158 | 0.240 |
Why?
|
| Protein Transport | 5 | 2014 | 1951 | 0.240 |
Why?
|
| Erythrocytes | 4 | 2018 | 2418 | 0.240 |
Why?
|
| Agglutination Tests | 2 | 2014 | 43 | 0.230 |
Why?
|
| Cell Nucleus Structures | 1 | 2004 | 15 | 0.230 |
Why?
|
| Transcription Factors | 7 | 2009 | 12171 | 0.220 |
Why?
|
| Carboxyhemoglobin | 3 | 2021 | 83 | 0.220 |
Why?
|
| Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
| Sjogren's Syndrome | 4 | 2020 | 241 | 0.220 |
Why?
|
| Mice, Knockout | 13 | 2021 | 14488 | 0.210 |
Why?
|
| Cell Line | 12 | 2020 | 15602 | 0.200 |
Why?
|
| Liver Failure | 1 | 2004 | 252 | 0.200 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2009 | 424 | 0.200 |
Why?
|
| Deltoid Muscle | 1 | 2021 | 19 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2018 | 2300 | 0.190 |
Why?
|
| Spinal Cord Ischemia | 1 | 2023 | 94 | 0.190 |
Why?
|
| COS Cells | 3 | 2018 | 1135 | 0.190 |
Why?
|
| Viral Proteins | 2 | 2005 | 1802 | 0.190 |
Why?
|
| Poisons | 1 | 2021 | 37 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1999 | 783 | 0.180 |
Why?
|
| Oxygen | 4 | 2021 | 4270 | 0.180 |
Why?
|
| Meniere Disease | 2 | 2000 | 164 | 0.180 |
Why?
|
| Cellular Structures | 1 | 2020 | 9 | 0.180 |
Why?
|
| Tretinoin | 1 | 2004 | 525 | 0.180 |
Why?
|
| Myositis | 1 | 2024 | 269 | 0.180 |
Why?
|
| Lung | 12 | 2021 | 10101 | 0.180 |
Why?
|
| Inflammation | 5 | 2017 | 10873 | 0.180 |
Why?
|
| Phosphorylation | 6 | 2020 | 8316 | 0.180 |
Why?
|
| Homeostasis | 4 | 2020 | 3348 | 0.170 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 2013 | 41 | 0.170 |
Why?
|
| NAD | 2 | 2021 | 618 | 0.170 |
Why?
|
| Immunoassay | 3 | 2020 | 746 | 0.170 |
Why?
|
| Blood Pressure | 8 | 2021 | 8543 | 0.170 |
Why?
|
| Gene Expression Regulation | 12 | 2020 | 11930 | 0.170 |
Why?
|
| Cytosol | 1 | 2023 | 887 | 0.170 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 3445 | 0.170 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2019 | 42 | 0.170 |
Why?
|
| Smad Proteins | 2 | 2020 | 157 | 0.170 |
Why?
|
| Pulmonary Circulation | 2 | 2019 | 745 | 0.160 |
Why?
|
| Pulmonary Artery | 8 | 2018 | 1946 | 0.160 |
Why?
|
| Humans | 90 | 2024 | 768171 | 0.160 |
Why?
|
| GTP-Binding Proteins | 5 | 1991 | 948 | 0.160 |
Why?
|
| Diving | 1 | 2019 | 43 | 0.160 |
Why?
|
| Air | 2 | 2020 | 187 | 0.160 |
Why?
|
| Arginase | 1 | 2019 | 81 | 0.160 |
Why?
|
| Electricity | 2 | 2020 | 175 | 0.160 |
Why?
|
| Rabbits | 3 | 2018 | 4773 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 253 | 0.160 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 17142 | 0.160 |
Why?
|
| Protein Array Analysis | 3 | 2014 | 399 | 0.150 |
Why?
|
| Dermatomyositis | 1 | 2021 | 259 | 0.150 |
Why?
|
| Renal Circulation | 1 | 2019 | 291 | 0.150 |
Why?
|
| Salivary Glands | 1 | 2020 | 231 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2023 | 1505 | 0.150 |
Why?
|
| Activin Receptors, Type II | 2 | 2016 | 122 | 0.150 |
Why?
|
| Immunodominant Epitopes | 1 | 1999 | 244 | 0.150 |
Why?
|
| Antisickling Agents | 1 | 2018 | 72 | 0.150 |
Why?
|
| Respiration | 2 | 2021 | 1665 | 0.150 |
Why?
|
| Endotoxemia | 1 | 2019 | 198 | 0.150 |
Why?
|
| Iron-Dextran Complex | 1 | 2017 | 14 | 0.150 |
Why?
|
| Adipogenesis | 1 | 2020 | 371 | 0.140 |
Why?
|
| RNA Stability | 3 | 2011 | 320 | 0.140 |
Why?
|
| Hypertension | 5 | 2019 | 8616 | 0.140 |
Why?
|
| HL-60 Cells | 4 | 2004 | 364 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2022 | 1009 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2006 | 1730 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 210 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 152 | 0.140 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1497 | 0.140 |
Why?
|
| Lipopolysaccharides | 3 | 2017 | 2222 | 0.140 |
Why?
|
| Mesons | 2 | 2014 | 28 | 0.140 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 1281 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2014 | 5028 | 0.140 |
Why?
|
| Carboxylic Acids | 1 | 2017 | 91 | 0.130 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 18349 | 0.130 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2016 | 48 | 0.130 |
Why?
|
| Receptors, LDL | 1 | 2019 | 493 | 0.130 |
Why?
|
| Male | 47 | 2024 | 364731 | 0.130 |
Why?
|
| Epoxide Hydrolases | 1 | 2016 | 122 | 0.130 |
Why?
|
| Disulfides | 1 | 2018 | 466 | 0.130 |
Why?
|
| Macrophages | 3 | 2020 | 5802 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 859 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 5 | 2001 | 911 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1266 | 0.120 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2016 | 225 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2004 | 1750 | 0.120 |
Why?
|
| Phenylephrine | 1 | 2016 | 292 | 0.120 |
Why?
|
| Drug Contamination | 1 | 2016 | 151 | 0.120 |
Why?
|
| Turpentine | 1 | 2014 | 10 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 717 | 0.120 |
Why?
|
| Ear, Inner | 1 | 1999 | 426 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2021 | 8142 | 0.120 |
Why?
|
| Irritants | 1 | 2014 | 43 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 1754 | 0.120 |
Why?
|
| Natriuretic Peptides | 1 | 2016 | 156 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2019 | 1209 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 243 | 0.120 |
Why?
|
| Sheep | 4 | 2020 | 1451 | 0.120 |
Why?
|
| Amino Acid Sequence | 10 | 2005 | 13422 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 2000 | 1989 | 0.120 |
Why?
|
| Quinolines | 1 | 2020 | 772 | 0.120 |
Why?
|
| Vitamin K | 1 | 2017 | 314 | 0.110 |
Why?
|
| Hexokinase | 1 | 2014 | 124 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2006 | 11095 | 0.110 |
Why?
|
| Hemolysis | 1 | 2016 | 417 | 0.110 |
Why?
|
| Temperature | 2 | 2018 | 2234 | 0.110 |
Why?
|
| Neutrons | 1 | 2014 | 78 | 0.110 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 2 | 2007 | 28 | 0.110 |
Why?
|
| Biological Availability | 1 | 2014 | 391 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2016 | 393 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 874 | 0.110 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 4620 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2023 | 3655 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1995 | 418 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 588 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2022 | 1901 | 0.110 |
Why?
|
| Female | 38 | 2024 | 397187 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 110 | 0.110 |
Why?
|
| Metals | 1 | 2018 | 713 | 0.110 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2013 | 72 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2022 | 4939 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2007 | 9617 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4585 | 0.110 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 1082 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 518 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2016 | 2451 | 0.100 |
Why?
|
| Wakefulness | 1 | 2020 | 1284 | 0.100 |
Why?
|
| Sulfides | 2 | 2024 | 171 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 681 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 2138 | 0.100 |
Why?
|
| Triazoles | 1 | 2018 | 904 | 0.100 |
Why?
|
| Germ-Line Mutation | 2 | 2012 | 1885 | 0.100 |
Why?
|
| Molecular Sequence Data | 12 | 2008 | 17623 | 0.100 |
Why?
|
| Kidney | 5 | 2019 | 7064 | 0.100 |
Why?
|
| Rats | 14 | 2021 | 23782 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 3772 | 0.100 |
Why?
|
| Allergy and Immunology | 1 | 2013 | 175 | 0.100 |
Why?
|
| Multigene Family | 1 | 1995 | 1081 | 0.100 |
Why?
|
| Hypergammaglobulinemia | 1 | 2012 | 71 | 0.100 |
Why?
|
| Immune Sera | 2 | 2007 | 605 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2012 | 696 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 575 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2016 | 1105 | 0.090 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 1304 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2018 | 841 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2004 | 2810 | 0.090 |
Why?
|
| Fibrosis | 2 | 2016 | 2081 | 0.090 |
Why?
|
| Gene Deletion | 3 | 2021 | 2674 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2016 | 1097 | 0.090 |
Why?
|
| Critical Illness | 1 | 2024 | 2755 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 1160 | 0.090 |
Why?
|
| Acetylesterase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Rheumatology | 3 | 2013 | 617 | 0.090 |
Why?
|
| Brain | 6 | 2021 | 27362 | 0.090 |
Why?
|
| Germ Cells | 1 | 2014 | 644 | 0.090 |
Why?
|
| Sodium | 1 | 2016 | 1597 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3428 | 0.090 |
Why?
|
| Cell Transformation, Viral | 1 | 2012 | 530 | 0.090 |
Why?
|
| Protein Binding | 4 | 2018 | 9343 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 99 | 0.090 |
Why?
|
| Hep G2 Cells | 3 | 2016 | 378 | 0.090 |
Why?
|
| Cattle | 5 | 2008 | 3819 | 0.090 |
Why?
|
| Arsenites | 2 | 2007 | 65 | 0.080 |
Why?
|
| Equipment Design | 1 | 2018 | 3522 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2016 | 2234 | 0.080 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 175 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 1065 | 0.080 |
Why?
|
| Livedo Reticularis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1606 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 10763 | 0.080 |
Why?
|
| Paraproteinemias | 1 | 2012 | 252 | 0.080 |
Why?
|
| Mice, Transgenic | 6 | 2020 | 9561 | 0.080 |
Why?
|
| Cloning, Molecular | 7 | 2003 | 4168 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2057 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2016 | 4194 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1133 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2011 | 352 | 0.080 |
Why?
|
| Hepatocytes | 2 | 2018 | 1247 | 0.080 |
Why?
|
| Binding Sites | 4 | 2013 | 6019 | 0.080 |
Why?
|
| Pneumonia | 1 | 2020 | 2163 | 0.080 |
Why?
|
| Amino Acid Oxidoreductases | 3 | 1995 | 149 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 2725 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 2 | 2007 | 178 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 1676 | 0.080 |
Why?
|
| Androgens | 1 | 2016 | 1281 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2982 | 0.080 |
Why?
|
| Terminology as Topic | 2 | 2013 | 1542 | 0.080 |
Why?
|
| Leukocytes | 1 | 1996 | 2034 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2893 | 0.080 |
Why?
|
| Myocardium | 3 | 2018 | 4790 | 0.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1483 | 0.070 |
Why?
|
| Epitopes | 1 | 1994 | 2527 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 1931 | 0.070 |
Why?
|
| Arabidopsis | 1 | 2011 | 466 | 0.070 |
Why?
|
| Indoles | 2 | 2006 | 1836 | 0.070 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 2230 | 0.070 |
Why?
|
| Biopsy | 2 | 2017 | 6792 | 0.070 |
Why?
|
| Protons | 1 | 2013 | 1113 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1988 | 310 | 0.070 |
Why?
|
| Middle Aged | 23 | 2024 | 223487 | 0.070 |
Why?
|
| Heart Diseases | 2 | 2020 | 2819 | 0.070 |
Why?
|
| Calcinosis | 1 | 2016 | 1482 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 2029 | 0.070 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2007 | 35 | 0.070 |
Why?
|
| Endonucleases | 1 | 2010 | 371 | 0.070 |
Why?
|
| Peptide Library | 1 | 2008 | 351 | 0.070 |
Why?
|
| Homozygote | 1 | 2012 | 1779 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5902 | 0.070 |
Why?
|
| Androstanols | 2 | 2017 | 47 | 0.070 |
Why?
|
| Base Sequence | 8 | 2008 | 12422 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2014 | 4034 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2008 | 528 | 0.070 |
Why?
|
| Rheumatic Diseases | 1 | 2013 | 659 | 0.070 |
Why?
|
| Peptide Initiation Factors | 1 | 2006 | 53 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 346 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2007 | 2857 | 0.070 |
Why?
|
| Adenoviridae | 3 | 2017 | 1093 | 0.060 |
Why?
|
| Phospholipids | 1 | 1989 | 787 | 0.060 |
Why?
|
| Mutation | 6 | 2024 | 30237 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1642 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2007 | 3140 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 2065 | 0.060 |
Why?
|
| Serine | 2 | 2005 | 831 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 9527 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4428 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2021 | 662 | 0.060 |
Why?
|
| Centromere | 1 | 2004 | 214 | 0.060 |
Why?
|
| Transcription, Genetic | 5 | 2007 | 7609 | 0.060 |
Why?
|
| Cell Division | 2 | 1998 | 4477 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3229 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 18065 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 1966 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3238 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6568 | 0.050 |
Why?
|
| Electrodes | 2 | 2016 | 617 | 0.050 |
Why?
|
| Gene Expression | 6 | 2016 | 7601 | 0.050 |
Why?
|
| Glutathione Disulfide | 1 | 2023 | 32 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9540 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 930 | 0.050 |
Why?
|
| Gene Products, vif | 1 | 2002 | 31 | 0.050 |
Why?
|
| Quinones | 1 | 2022 | 79 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 1984 | 227 | 0.050 |
Why?
|
| Metronidazole | 1 | 2024 | 236 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2013 | 3074 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2014 | 11677 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2013 | 703 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2012 | 1596 | 0.050 |
Why?
|
| Sulfur | 1 | 2023 | 158 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 444 | 0.050 |
Why?
|
| Virus Activation | 1 | 2004 | 324 | 0.050 |
Why?
|
| Liver | 2 | 2018 | 7578 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2007 | 1065 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2007 | 1408 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2016 | 2916 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11519 | 0.050 |
Why?
|
| Reperfusion | 1 | 2023 | 266 | 0.050 |
Why?
|
| Paraplegia | 1 | 2023 | 161 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2010 | 1361 | 0.050 |
Why?
|
| Calcium | 1 | 2015 | 5792 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2011 | 1726 | 0.050 |
Why?
|
| Half-Life | 2 | 2018 | 651 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 693 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 15662 | 0.050 |
Why?
|
| Exanthema | 2 | 2021 | 503 | 0.050 |
Why?
|
| Nitroso Compounds | 2 | 1998 | 71 | 0.050 |
Why?
|
| Genetic Markers | 1 | 1988 | 2603 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 1169 | 0.050 |
Why?
|
| Aged | 14 | 2024 | 171502 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 622 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 1984 | 284 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10840 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 485 | 0.050 |
Why?
|
| Oral Ulcer | 1 | 2021 | 96 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13677 | 0.050 |
Why?
|
| Time Factors | 4 | 2017 | 40220 | 0.050 |
Why?
|
| Knee Joint | 2 | 2006 | 1683 | 0.040 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2001 | 91 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 3 | 1 | 2020 | 18 | 0.040 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 21 | 0.040 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2020 | 8 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2020 | 64 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2682 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 624 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 724 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 297 | 0.040 |
Why?
|
| Foam Cells | 1 | 2020 | 68 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2001 | 306 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10266 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2009 | 2171 | 0.040 |
Why?
|
| Parotid Neoplasms | 1 | 2001 | 158 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 221 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2019 | 32 | 0.040 |
Why?
|
| DNA | 5 | 1992 | 7213 | 0.040 |
Why?
|
| Methemoglobin | 1 | 2018 | 25 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2012 | 2295 | 0.040 |
Why?
|
| Glutathione | 2 | 1998 | 589 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2000 | 355 | 0.040 |
Why?
|
| Solubility | 2 | 2016 | 1086 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1999 | 342 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2019 | 41753 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 2152 | 0.040 |
Why?
|
| 3' Untranslated Regions | 2 | 2013 | 515 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 1988 | 1294 | 0.040 |
Why?
|
| S-Nitrosothiols | 1 | 2018 | 35 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1998 | 126 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14729 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 2019 | 203 | 0.040 |
Why?
|
| Nitrites | 1 | 2018 | 156 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1972 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2000 | 2179 | 0.040 |
Why?
|
| Adult | 14 | 2020 | 223646 | 0.040 |
Why?
|
| Biological Evolution | 1 | 1984 | 1076 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 1 | 2018 | 113 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 13091 | 0.040 |
Why?
|
| Arthralgia | 1 | 2021 | 459 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9262 | 0.040 |
Why?
|
| Freezing | 1 | 2018 | 311 | 0.040 |
Why?
|
| Antibodies | 1 | 2005 | 2421 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 155 | 0.040 |
Why?
|
| Osteoarthritis | 3 | 1991 | 1072 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2023 | 776 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 2016 | 2342 | 0.040 |
Why?
|
| Heart Failure | 1 | 2021 | 11879 | 0.040 |
Why?
|
| Luminescence | 1 | 2017 | 108 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1836 | 0.030 |
Why?
|
| Alleles | 3 | 2016 | 6894 | 0.030 |
Why?
|
| Iridium | 1 | 2016 | 30 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 411 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 16044 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 467 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 6124 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4149 | 0.030 |
Why?
|
| Tracheotomy | 1 | 2017 | 174 | 0.030 |
Why?
|
| Heart Rate | 2 | 2018 | 4214 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2020 | 579 | 0.030 |
Why?
|
| Superoxides | 1 | 2017 | 389 | 0.030 |
Why?
|
| Collodion | 1 | 1995 | 34 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2004 | 2874 | 0.030 |
Why?
|
| Mice, Inbred NZB | 1 | 1995 | 57 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2019 | 706 | 0.030 |
Why?
|
| Peptide Fragments | 3 | 2016 | 5151 | 0.030 |
Why?
|
| Filtration | 1 | 2016 | 229 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 378 | 0.030 |
Why?
|
| Vasodilation | 1 | 2020 | 967 | 0.030 |
Why?
|
| Hearing Loss, Bilateral | 1 | 1995 | 53 | 0.030 |
Why?
|
| Osteoarthritis, Knee | 1 | 2006 | 1251 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 144 | 0.030 |
Why?
|
| Plasma Gases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1995 | 293 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 704 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 384 | 0.030 |
Why?
|
| Macromolecular Substances | 4 | 1993 | 1435 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1995 | 139 | 0.030 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2015 | 88 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 363 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1995 | 421 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2015 | 398 | 0.030 |
Why?
|
| Metals, Heavy | 1 | 2016 | 149 | 0.030 |
Why?
|
| Saliva | 1 | 2020 | 853 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 429 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1995 | 636 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 131 | 0.030 |
Why?
|
| Mifepristone | 1 | 2015 | 151 | 0.030 |
Why?
|
| Bronchi | 1 | 2018 | 850 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2016 | 224 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2415 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1557 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2015 | 213 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4058 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2013 | 14 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1614 | 0.030 |
Why?
|
| Mitosis | 1 | 1999 | 1178 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10478 | 0.030 |
Why?
|
| Body Temperature | 1 | 2017 | 780 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 347 | 0.030 |
Why?
|
| Cytokines | 2 | 2016 | 7452 | 0.030 |
Why?
|
| Fentanyl | 1 | 2017 | 451 | 0.030 |
Why?
|
| Trachea | 1 | 2020 | 1095 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1984 | 3447 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15833 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 1968 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 562 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 2334 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 966 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 250 | 0.030 |
Why?
|
| Adipocytes | 1 | 2020 | 1199 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 2004 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 1995 | 630 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2013 | 30 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 2173 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2021 | 4206 | 0.030 |
Why?
|
| Immunologic Tests | 1 | 2013 | 104 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 456 | 0.030 |
Why?
|
| Electrons | 1 | 2014 | 264 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2020 | 873 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 942 | 0.030 |
Why?
|
| Interferons | 1 | 1996 | 720 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 574 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 1064 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2019 | 6610 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2819 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 591 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2748 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 2015 | 534 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2016 | 751 | 0.020 |
Why?
|
| Resuscitation | 1 | 2016 | 679 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 1535 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 838 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1094 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2011 | 139 | 0.020 |
Why?
|
| Aorta | 1 | 2019 | 2045 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15949 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1904 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2011 | 83 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2011 | 81 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1674 | 0.020 |
Why?
|
| Mitogens | 1 | 1991 | 229 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 874 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2167 | 0.020 |
Why?
|
| Progesterone | 1 | 2015 | 752 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 13013 | 0.020 |
Why?
|
| Swine | 1 | 2021 | 5997 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3740 | 0.020 |
Why?
|
| Ketamine | 1 | 2017 | 527 | 0.020 |
Why?
|
| Genes | 3 | 1989 | 1824 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2013 | 563 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1191 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 301 | 0.020 |
Why?
|
| Phenotype | 2 | 2019 | 16726 | 0.020 |
Why?
|
| Troponin I | 1 | 2015 | 662 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2013 | 684 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4528 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4786 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3590 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1854 | 0.020 |
Why?
|
| Kinetics | 3 | 1993 | 6330 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2016 | 742 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4363 | 0.020 |
Why?
|
| Finger Joint | 1 | 1990 | 108 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 168 | 0.020 |
Why?
|
| Antirheumatic Agents | 2 | 2010 | 1381 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6512 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1563 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2011 | 271 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1993 | 1470 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2683 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 296 | 0.020 |
Why?
|
| Troponin | 1 | 2013 | 535 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein L | 1 | 2008 | 1 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2939 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2003 | 1228 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2005 | 3056 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 423 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2010 | 386 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 2 | 1998 | 23 | 0.020 |
Why?
|
| Ligands | 1 | 2015 | 3284 | 0.020 |
Why?
|
| Hypesthesia | 1 | 2009 | 106 | 0.020 |
Why?
|
| Polyarteritis Nodosa | 1 | 2009 | 70 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1988 | 261 | 0.020 |
Why?
|
| Lymphocytes | 2 | 2002 | 2614 | 0.020 |
Why?
|
| Poly A | 1 | 2008 | 180 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2020 | 3334 | 0.020 |
Why?
|
| Genetic Vectors | 3 | 1998 | 3403 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2131 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 2125 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2009 | 179 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 809 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 667 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1524 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 1526 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5622 | 0.020 |
Why?
|
| Italy | 1 | 2009 | 856 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1250 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3814 | 0.020 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2009 | 173 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2012 | 1864 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5315 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2021 | 54924 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2016 | 1751 | 0.020 |
Why?
|
| Prednisone | 1 | 2012 | 1567 | 0.020 |
Why?
|
| Placenta | 1 | 2016 | 1725 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 846 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15869 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1305 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 2007 | 302 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2008 | 781 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 279 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3986 | 0.020 |
Why?
|
| Karyotyping | 1 | 1988 | 1177 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3623 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3806 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1752 | 0.020 |
Why?
|
| Endothelium | 2 | 2001 | 768 | 0.020 |
Why?
|
| Nitroprusside | 2 | 1997 | 272 | 0.020 |
Why?
|
| Tristetraprolin | 1 | 2005 | 40 | 0.020 |
Why?
|
| Polyribosomes | 1 | 2005 | 109 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1987 | 445 | 0.020 |
Why?
|
| Testosterone | 1 | 2016 | 2491 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 14783 | 0.020 |
Why?
|
| HIV-1 | 1 | 2002 | 6963 | 0.020 |
Why?
|
| Hydroxychloroquine | 1 | 2009 | 426 | 0.010 |
Why?
|
| Risk | 1 | 2017 | 9613 | 0.010 |
Why?
|
| Threonine | 1 | 2005 | 273 | 0.010 |
Why?
|
| Hip Joint | 1 | 1991 | 1018 | 0.010 |
Why?
|
| Exons | 1 | 2010 | 2394 | 0.010 |
Why?
|
| 14-3-3 Proteins | 1 | 2005 | 221 | 0.010 |
Why?
|
| Dry Eye Syndromes | 1 | 2009 | 385 | 0.010 |
Why?
|
| Zebrafish | 1 | 2015 | 3035 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 39354 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2909 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2862 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2744 | 0.010 |
Why?
|
| Leg | 1 | 2009 | 1088 | 0.010 |
Why?
|
| Genetic Code | 1 | 1984 | 139 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3706 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 174 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3436 | 0.010 |
Why?
|
| Europe | 1 | 2010 | 3436 | 0.010 |
Why?
|
| Spodoptera | 1 | 2003 | 140 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3610 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3390 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2003 | 115 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 24318 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2010 | 3781 | 0.010 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 51 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2007 | 1419 | 0.010 |
Why?
|
| U937 Cells | 1 | 2002 | 260 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4861 | 0.010 |
Why?
|
| Sex Factors | 1 | 2016 | 10632 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2017 | 42669 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 2004 | 338 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2010 | 22290 | 0.010 |
Why?
|
| Societies, Medical | 2 | 1991 | 3968 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 1683 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 6082 | 0.010 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 2001 | 10 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 564 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 740 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 362 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2001 | 219 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 500 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8648 | 0.010 |
Why?
|
| 3T3 Cells | 2 | 1992 | 1084 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1984 | 901 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 60066 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12795 | 0.010 |
Why?
|
| Echocardiography | 1 | 2013 | 5047 | 0.010 |
Why?
|
| Stomach | 1 | 2004 | 701 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1987 | 1502 | 0.010 |
Why?
|
| Fetus | 1 | 2007 | 1883 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 2001 | 186 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 515 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 13045 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1104 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 1 | 1978 | 12 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36741 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 59626 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5891 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 4539 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20762 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8542 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9669 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 4249 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 1997 | 94 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 943 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2001 | 642 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1997 | 305 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 341 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1978 | 287 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2003 | 911 | 0.010 |
Why?
|
| Aspirin | 1 | 2009 | 3135 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1252 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1662 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1978 | 699 | 0.010 |
Why?
|
| Child | 2 | 2017 | 80917 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 2458 | 0.010 |
Why?
|
| Pain | 2 | 2009 | 5099 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 81760 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 3447 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1997 | 297 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2892 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 417 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 3161 | 0.010 |
Why?
|
| Radiography | 3 | 1991 | 6986 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 30255 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 65379 | 0.010 |
Why?
|
| Genome, Human | 1 | 2007 | 4446 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1993 | 100 | 0.010 |
Why?
|
| Bucladesine | 1 | 1993 | 118 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 1839 | 0.010 |
Why?
|
| Lasers | 1 | 1978 | 952 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1978 | 1080 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1207 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1992 | 44 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 2956 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 3703 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 1998 | 958 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1991 | 87 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1991 | 154 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1991 | 176 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 283 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1904 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1978 | 2634 | 0.010 |
Why?
|
| Heparin | 1 | 1978 | 1636 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1995 | 1688 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36535 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4355 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 9016 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1991 | 617 | 0.010 |
Why?
|
| Thrombin | 1 | 1991 | 600 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10397 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15453 | 0.000 |
Why?
|
| Adolescent | 2 | 2009 | 89169 | 0.000 |
Why?
|
| Multivariate Analysis | 2 | 1991 | 12077 | 0.000 |
Why?
|
| Chlorambucil | 1 | 1987 | 42 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3728 | 0.000 |
Why?
|
| Azathioprine | 1 | 1987 | 354 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1991 | 2357 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1991 | 2934 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1993 | 4178 | 0.000 |
Why?
|
| Ion Channels | 1 | 1988 | 1043 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 6231 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1990 | 6229 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1987 | 2227 | 0.000 |
Why?
|
| Methotrexate | 1 | 1987 | 1721 | 0.000 |
Why?
|
| Movement | 1 | 1986 | 1490 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1987 | 1205 | 0.000 |
Why?
|
| Immune Tolerance | 1 | 1987 | 2323 | 0.000 |
Why?
|
| Age Factors | 1 | 1986 | 18415 | 0.000 |
Why?
|
| United States | 1 | 1990 | 73039 | 0.000 |
Why?
|